Headline News about Anaptysbio Inc![]() ![]()
HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround
September 19, 2022
Via Benzinga
![]() ![]() ![]()
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
Via Benzinga
![]()
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 31, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|